Search Results - "Houot R"

Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry.

Authors: Dulery R Guiraud V Choquet S et al.

Source: Nature medicine [Nat Med] 2025 Jul; Vol. 31 (7), pp. 2452.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Authors: Houot R Bachy E Cartron G et al.

Source: Nature medicine [Nat Med] 2024 Jul; Vol. 30 (7), pp. 2089.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Author Index.

Source: Fundamental & Clinical Pharmacology. Jun2024 Supplement 1, Vol. 38, p213-226. 14p.

Outpatient Rescue With Stem Cells Boost for Refractory Hematotoxicity Following anti‐BCMA CAR T‐Cell Therapy: A Case Report.

Authors: Loukhnati, Mehdi Hebraud, Benjamin Cazaux, Marine et al.

Source: Case Reports in Hematology. 6/4/2026, Vol. 2026, p1-3. 3p.

Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.

Authors: Sesques P Manson G Cartron G et al.

Source: HemaSphere [Hemasphere] 2026 May 06; Vol. 10 (5), pp. e70356. Date of Electronic Publication: 2026 May 06 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

In vivo CAR therapies: Turning the patient into their own CAR factory.

Authors: Vilcot F Brugère CA Fuentealba J et al.

Source: HemaSphere [Hemasphere] 2026 Apr 29; Vol. 10 (5), pp. e70328. Date of Electronic Publication: 2026 Apr 29 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

NOTCH1 Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective Study.

Authors: Haméon C Houot R Gyan E et al.

Source: EJHaem [EJHaem] 2025 Sep 26; Vol. 6 (5), pp. e70146. Date of Electronic Publication: 2025 Sep 26 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE

A new era for transplant-ineligible R/R LBCL patients: what's changing?

Authors: Tarantini, Giuseppe Miccolis, Rosanna Maria Arcuti, Elena et al.

Source: Leukemia & Lymphoma. Apr2026, Vol. 67 Issue 5, p997-1004. 8p.

Author Index.

Source: Vox Sanguinis. Jun2023 Supplement 1, Vol. 118, p380-395. 16p.

Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis.

Authors: Galtier J Sesques P Dupont V et al.

Source: HemaSphere [Hemasphere] 2025 Dec 08; Vol. 9 (12), pp. e70263. Date of Electronic Publication: 2025 Dec 08 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric study.

Authors: Maguet R Eloit M Chinot O et al.

Source: Annals of hematology [Ann Hematol] 2025 Dec; Vol. 104 (12), pp. 6385-6390. Date of Electronic Publication: 2025 Nov 27.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study.

Authors: Lalanne S Osmont MN Triquet L et al.

Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Nov 06; Vol. 81 (4), pp. 721-727.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

A Large Room for Improvement in the Management of Relapsed/Refractory Large B-Cell Lymphoma in Türkiye: Real-World Outcomes in a Setting Without Access to T-Cell Redirecting Therapies.

Alternate Title: Nüks/Dirençli Büyük B-Hücreli Lenfomanın Tedavisinde Katedilecek Çok Yol Var: Bispesifik ve CAR-T Erişimi Olmayan Hastalarda Gerçek Yaşam Sonuçları.

Authors: Yılmaz, Umut Dal, Mehmet Sinan Ulaş, Turgay et al.

Source: Turkish Journal of Hematology. 2025, Vol. 42 Issue 4, p265-280. 16p.

Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of a Tertiary Centre.

Authors: Alonso-Carballo, Aser López, Marta Jiménez, María et al.

Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 5, p2044. 13p.

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Authors: Sarkozy C Chartier L Ribrag V et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Apr 24; Vol. 15 (1), pp. 78. Date of Electronic Publication: 2025 Apr 24.

Publication Type: Journal Article; Validation Study

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Acute Leukemia of Mixed B/Myeloid Lineage with Dual BCR::ABL1 and CBFβ::MYH11 Fusion Genes.

Alternate Title: Çift BCR::ABL1 ve CBFb::MYH11 Füzyon Genine Sahip Karma B/Miyeloid Kökenli Akut Lösemi.

Authors: Lu, Xulin Xiao, Jigang Cai, Xiaojin et al.

Source: Turkish Journal of Hematology. 2026, Vol. 43 Issue 2, p165-166. 2p.

Conventional and organic farms with more intensive management have lower soil functionality.

Authors: van Rijssel, Sophie Q. Koorneef, Guusje J. Veen, G. F. et al.

Source: Science. 4/25/2025, Vol. 388 Issue 6745, p410-415. 6p.

Large B-cell lymphoma: The LYSA pragmatic guidelines.

Authors: Sesques P Manson G Dubois S et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jan; Vol. 232, pp. 116070. Date of Electronic Publication: 2025 Dec 03.

Publication Type: Journal Article; Practice Guideline

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Authors: Steenhuis, Eline G. M. van Disseldorp, Lieke M. Jacobs, Femke J. C. et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p2019. 13p.

Quality of Life in CAR-T Cell Therapy.

Authors: Alati, Caterina Pitea, Martina Porto, Gaetana et al.

Source: Hematology Reports. Jun2026, Vol. 18 Issue 3, p40. 25p.